TrialJournal of Crohn's & colitis2025

Achievement of long-term treatment goals in upadacitinib-treated patients with moderately to severely active ulcerative colitis: a post hoc analysis of phase 3 trial data.

Julian Panés et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.